Leucita/Filgrastim AqVida (recombinant human G-CSF) solution for injection

25 mg, 50 mg Tablets Immunosuppressant

20 mg, 80 mg, 140 mg, 160 mg vial Indications: Treatment of breast cancer, special form of lung cancer, prostate cancer, gastric cancer and head or neck cancer

10 mg, 20 mg, 50 mg, 100 mg, 200 mg vialIndications: Treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, bladder cancer

200 mg, 1 g, 2 g vial Indications: Treatment of NSCLC, pancreatic cancer, bladder cancer, breast cancer

100 mg, 200 mg, 400 mg capsuleIndications: Treatment of chronic myeloid leukaemia, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

40 mg, 100 mg, 300 mg vial Indications: Treatment of advanced colorectal cancer

50 mg, 100 mg, 200 mg vialIndications: Treatment of advanced colorectal cancer

30 mg, 100 mg, 150 mg, 300 mg vial Indications: Treatment of ovarian cancer, breast cancer, advanced NSCLC, AIDS-related Kaposi‘s sarcoma

100 mg, 500 mg, 1 g vialIndication: Treatment of NSCLC

* Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

12.5 mg, 25 mg, 37.5 mg, 50 mg CapsuleIndications: Treatment of mRCC, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

Filling Sizes: 100 mg; 150 mg

Filling Sizes: 50 mg/ 0,5 ml; 100 mg/ 1 ml; 200 mg/ 2 ml